Prioritizing Clinical Candidates for Motor Recovery in Multiple Sclerosis

优先考虑多发性硬化症运动恢复的临床候选者

• 批准号: 475365
• 负责人: Kasheke Gracious
• 金额: $ 7.65万
• 依托单位: Dalhousie University (Nova Scotia)
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-11-01 至 2025-11-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=475365&lang=en
• 关键词: Experimental Autoimmune Encephalomyelitis; Kinematic Gait Analysis; Multiple Sclerosis; Neuroprotection; Remyelination

Multiple Sclerosis (also referred to as MS) is a chronic immune disorder of unknown cause commonly characterized by blurred vision or a loss of vision, problems with balance, and difficulties with brain function. The disease has no known cure and Canada h

多发性硬化症（也称为MS）是一种原因不明的慢性免疫疾病，通常以视力模糊或视力丧失、平衡问题和脑功能障碍为特征。这种疾病没有已知的治疗方法，加拿大